Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject for Postoperative Delirium in Hip Fracture
NCT05429749Phase 4Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jul 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Seoul National University Bundang Hospital. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05429749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05429749.